Delivery Order SPE2DB20D3505-SPE2DB25FV0D5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count units) under a firm fixed price contract valued at $10,700.20. The order, with an ultimate completion date of July 21, 2025, was competitively awarded without set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery to support federal medical procurement needs....
- The Defense Logistics Agency awarded a delivery order valued at $19,208.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 18, 2025, with a completion date of July 21, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract type. The order, valued at $4,520.58, is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designations, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,128.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. Issued on July 18, 2025, with an ultimate completion date of July 21, 2025, this firm fixed-price contract represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,954.01 on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price, competitively awarded contract represents a non-set-aside delivery order with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, consistent with...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Jardiance 25 mg tablets. The $64,016.96 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Jardiance 10 mg tablets to fulfill pharmaceutical needs. The $5,786.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $5,395.37. This is a firm fixed-price delivery order with a completion date of July 21, 2025. The contract carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $7,978.20 firm fixed-price delivery order contract for 90 units of the drug Jardiance 25 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- The Defense Logistics Agency (DLA) awarded a $81,903.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of July 21, 2025. This non-set-aside competitive award is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0D5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,128.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The prime IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's contract portfolio with the DLA demonstrates its capability to fulfill federal medical supply requirements through competitive procurement, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/18/25 |